Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study

Fantini, MC;
2023-01-01

Abstract

This prospective study reported 2 key results: (1) lack of seroconversion following 2 doses of COVID-19 vaccines is an independent predictor of SARS-CoV-2 infection; (2) treatments for IBD were not associated with increased risk of SARS-CoV-2 infection.
2023
biologics
SARS-CoV-2
Seroconversion
vaccine
Files in This Item:
File Size Format  
Macaluso FS et al Inflamm Bowel Dis 2023.pdf

open access

Type: versione pre-print
Size 248.44 kB
Format Adobe PDF
248.44 kB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie